Conventional treatment of mesothelioma cancer is mainly composed of three main options of surgery, chemotherapy or medical treatments were discovered radiation.Newer include the use of targeted therapies that address biological factors trigger the growth of mesothelioma could be a very more accurate and more efficient fight against this notoriously difficult, mesothelioma treatment, cancer.Mesothelioma is so difficult to treat because most often diagnosed when it, mesothelioma treatment, is already at an advanced stage and because it can take many forms of life.

Mesothelioma treatment today were designed for other types of cancer, mesothelioma treatment, without considering the factors that may be specific to, mesothelioma treatment, mesothelioma. This could be the reason many patients only partially responded to treatment, and the median survival is 12 months after therapy diagnosis.More address specific targeted Mechanisms of disease progression that can really help provide a better means of extending life average of mesothelioma patients. Targeted therapy refers to a new generation of cancer drugs to interfere with specific molecular targets, usually a protein or a receptor that is thought to have a crucial role in tumor growth, "said head writer to study Katalin, mesothelioma treatment, Dobra, MD, Ph.

D., Department of Laboratory Medicine at the Karolinska Institute in Stockholm, the treatment of cancer Sweden.Targeted, mesothelioma treatment, exploits our knowledge of recent key mechanism by which malignant cells, mesothelioma treatment, [] the need for cancer survival, and uses, mesothelioma treatment, the special properties of mesothelioma cells to develop new therapeutic strategies, process says.The Dr. Dobra begins with screening to identify the molecular, mesothelioma treatment, characteristics of a tumor, mesothelioma treatment, and its behavior, which grow and expand.

Then the researchers therapies to test various cells in the laboratory to see if they interfere with this process. not before a new therapy can be tested on patients in clinical trials, mesothelioma treatment, .So far, Dr. Dobra team identified three possible molecular targets, each with its own processing capacity: the proteasome subunits are groups of enzymes that regulate progression and cell death. Potential treatment: medicines called proteasome inhibitors has been shown to halt the growth of mesothelioma cells.

thioredoxin system contains components that are produced differently in cancer and cancer of mesothelial cells and is thought to contribute to cell survival in mesothelioma. Potential treatment: in collaboration with other groups, Dr. Dobra has shown that selenite minerals can lead to cell death saving mesothelioma cells healthy. proteoglycans (PG) are a class of proteins that differ by type of mesothelioma cells, mesothelioma treatment, . They work affecting growth factors that help cells grow and divide mesothelioma.

Potential treatment: sequences of oligosaccharides, which are strings of molecules sugar,, mesothelioma treatment, may interfere with the work of these approaches PGs.One targeted proteasome inhibitors, is currently being tested in clinical trials. The other two methods are very promising, but further research is needed before it can be tested on patients. Other goals cancer are also investigated.The next step in research is to combine several traditional experimentalto treatmentsboth and see which ones are most effective in targeting cancer mesothelioma, said Dr.

Dobra. Attacking tumors of many different possible approaches to ensure maximum benefit patients with mesothelioma.